Page last updated: 2024-09-04
ampelopsin and Melanoma
ampelopsin has been researched along with Melanoma in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chen, YM; Peng, Y; Sun, HY; Yue, JQ; Zhong, ZJ; Zhou, DZ | 1 |
| Chen, H; Li, M; Liu, B; Liu, J; Zeng, G; Zhang, Q; Zhu, R | 1 |
Other Studies
2 other study(ies) available for ampelopsin and Melanoma
| Article | Year |
|---|---|
Dihydromyricetin induces apoptosis and cytoprotective autophagy through ROS-NF-κB signalling in human melanoma cells.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cytoprotection; Drug Screening Assays, Antitumor; Flavonols; Humans; Melanoma; NF-kappa B; Reactive Oxygen Species; Signal Transduction; Skin Neoplasms | 2017 |
Dihydromyricetin induces cell cycle arrest and apoptosis in melanoma SK-MEL-28 cells.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Flavonols; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Neoplasm Proteins | 2014 |